Evidence map›Paper›PMID 41080950›Full record

ArticleFrontiers in medicine2025

Risk assessment and management of polypharmacy in the Geriatric Interdisciplinary Team: a case report.

Jing-Wen Guo, He Zhao, Wen Tian, Shuang Cai

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing-Wen GuoDepartment of Pharmacy, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
He ZhaoDepartment of Pharmacy, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
Wen TianDepartment of Geriatrics, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Shuang CaiDepartment of Pharmacy, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Older patients frequently experience the coexistence of multiple diseases. The conventional single-discipline diagnostic and treatment model is insufficient to comprehensively address all concurrent conditions, thereby necessitating a multi-disciplinary collaborative approach. The Geriatric Interdisciplinary Team represents an innovative diagnostic and treatment paradigm tailored for older patients, with clinical pharmacists serving as integral members of this team. This article presents a case report of the application of Geriatric Interdisciplinary Team, involving the participation of a clinical pharmacist, aiming to provide practical insights and experiences of this model for clinical pharmacists.

Indexed as

case reportclinical pharmacistsGeriatric Interdisciplinary Teamindividualized treatmentpolypharmacy

Identifiers

PMID41080950
PMCPMC12511001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.